Genflows gene therapy hits key trial goal in ageing dogs
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) the London-listed biotechnology company developing gene therapies for age-related diseases,...…
0,023€
15,00%
Echtzeit-Aktienkurs Genflow Biosciences PLC
Bid:
Ask:
Nachrichten zur Genflow Biosciences PLC Aktie
Thor Explorations, Strategic Minerals, London BTC, Genflow Biosciences, Pantheon International, Frontier IP - Small Cap Week in Review
…
Genflow wins fast-track US examination for foundational longevity patent
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the London-listed longevity research company, said the United States Patent and Trademark Office...…
Genflow Biosciences dog trial continues to show longevity improvements
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) said improvements recorded in its SLAB aged-dog gene therapy trial were maintained three months...…
SIRT6 gene therapy shows promise in aged dogs
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO, Dr Eric Leire, talked with Proactive about the companys upcoming presentation at the Animal...…
Genflow surges 14% as animal health giants circle canine ageing gene therapy
The AIM-listed biotechs SIRT6 programme is attracting a widening group of Tier-1 industry evaluators, sending shares to 2.85p. Genflow Biosciences…
Genflow widens confidentiality agreements with animal health companies over dog gene therapy data
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the gene therapy developer, has signed additional confidentiality agreements with Tier-1 global...…
Genflow Biosciences strikes LNP delivery deal with mRNA vaccine technology pioneer
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), a biotechnology company focused on gene therapies for age-related diseases, has entered a...…
Genflow Biosciences expands SIRT6 patent protection into muscular diseases
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the gene therapy developer, has announced the international publication of a Patent Cooperation...…
Genflow CEO on promising SLAB trial data
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO, Dr Eric Leire, talked with Proactive about encouraging results from the SLAB (Sarcopenia…
Genflow reports sustained safety and efficacy three months after gene therapy dosing in dog trial
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the European biotechnology company focused on gene therapies for age-related diseases, has...…
Genflow Biosciences raises £800,000 to fund gene therapy programmes
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the biotechnology company focused on gene therapies for age-related diseases, confirmed it has...…
Genflow Biosciences: AGM and partnership strategy
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire talked with Proactive about the company’s latest RNS regarding its upcoming…
Genflow Biosciences: AGM and partnership strategy
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire talked with Proactive about the company’s latest RNS regarding its upcoming…
Genflow shares jump 19.5% on positive interim data from dog gene therapy trial
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) shares opened 19.5% higher at 2.27p after the company reported positive preliminary interim results...…
Genflow reports positive interim data from SIRT6 gene therapy trial in aged dogs
Biotechnology group says treated animals showed improved survival and functional measures in early-stage study Genflow Biosciences Ltd (LSE:GENF,...…
Genflow CEO talks through dog study and why partnerships
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) this week reaffirmed its focus on capital efficiency and pipeline advancement following a €4...…
Genflow CEO talks through dog study and why partnerships
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) this week reaffirmed its focus on capital efficiency and pipeline advancement following a €4...…
Genflow Biosciences confirms priorities as it confirms progress in €4m funding
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) told investors it has received administrative approval for previously announced funding support of...…
Genflow shares jump as biotech appoints new chairman
Shares in Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) rose 13% to 2.08p after the company named a new chairman, a move…
Genflow names new chairman as gene therapy group looks to next phase
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) has appointed a new chairman as the London-listed biotechnology company steps up efforts to push...…
Genflow is ready for “a year of catalysts”
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF) this week outlined a series of near- and medium-term catalysts as the company enters what…